Sanna-Maria Käkönen

Non-clinical Development (oncology), Scientific Marketing, Scientific Writing

CONELIS expert Sanna-Maria Käkönen

CEO, founder/Aurexel Life Sciences Ltd.

Askainen, Finland

English, Swedish, Finnish

Services offered worldwide

www.aurexel.com

Contact Me

Send me an Turn on Javascript!

Information


  • Aurexel provides scientific writing, scientific marketing and business development services tailored especially for life sciences industry and organizations. Our scientific writing expertise can help our customers maximize their investment in research by ensuring fast and efficient reporting or publishing of research data. Our scientific marketing and business development services will help our customers capitalize their scientific and technical expertise and turn their competency into commercial and international success and grow their business.

About Me

 Expert in translational research

  • Over 20 years of experience of international and national research projects in drug and biomarker discovery and development for pharmaceutical and diagnostic companies
  • Early and translational research project management in drug development and companion diagnostics
  • Evaluation of new targets and compounds, diagnostic methods and biomarkers available for in-licensing in oncology
  • Preclinical in vivo imaging techniques and biomarker research, scouting and evaluation of in vivo animalmodels for preclinical CROs and pharmaceutical companies

 

Collaborator and facilitator

  • Collaboration with academic groups and participation in international networks
  • Working as a facilitator between contract research organizations or academic groups and diagnostic/biotech/pharma companies in diverse type of projects
  • Successful track record of key customer relationship management

Qualifications

  • Adjunct Professor (anatomy) at University of Turku
  • Ph.D. (Biotechnology)

Following a distinguished international academic career, Dr. Käkönen continued her work in cancer biology and cancer drug development for over a decade in the international pharmaceutical industry, first with Schering (later Bayer) in Berlin and later with Amgen, before finally founding  Aurexel Consulting in 2012. Expert in translational research